20/05/2025
Today, on International Clinical Trials Day, we at Ameli-BioGroup salute the dedication, innovation and collaboration that power clinical research. đđŹ
Since James Lindâs pioneering scurvy study in 1747âthe very first randomised trialâevery protocol, every volunteer and every data point has brought us closer to safer, more effective treatments.
Interesting facts đ
⢠𧪠Origin story: 20 May marks Lindâs 1747 trial aboard HMS Salisbury, in which he proved that citrus fruit prevents scurvyâlaying the groundwork for modern, evidenceâbased medicine.
⢠đ High bar: despite thousands of trials underway worldwide, only 10 % of drug candidates entering human testing ultimately gain approval.
⢠ⳠRecruitment hurdles: 80 % of trials miss their patientârecruitment deadlines, costing the industry up to $40 billion annually in delays.
⢠đ Decentralised future: the global decentralised clinicalâtrials market was worth $9.6 billion in 2024 and is projected to more than double to $21.3 billion by 2030, as patientâcentred models reshape how studies are run.
At Ameli-BioGroup, weâre proud to support Phase IIâIV trials across therapeutic areas, leveraging cuttingâedge technology and patientâcentred approaches to accelerate breakthroughs.
Today we reaffirm our pledge to:
⢠Uphold the highest ethical and quality standards
⢠Foster transparent communication with all stakeholders
⢠Champion diversity and inclusion in every study design
Join us in celebrating the power of clinical trials to change lives! đ
đ Learn more about our ongoing studies: https://lnkd.in/ew9cSFjw
-Biogroup LTD